[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:superoxide-dismutase-cu-zn":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Superoxide Dismutase [Cu-Zn]",4,[7,15,22,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05407324","Dazucorilant in Patients With Amyotrophic Lateral Sclerosis",[11],"Phase 2","RECRUITING","2026-08-26T02:16:44.178623Z","2026-07-05T05:32:16.799228Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07290062","A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)",[19],"Phase 1","2026-08-26T02:18:36.226508Z","2026-05-05T02:43:27.494050Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07259980","A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)",[],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.681439Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT03865420","Amyotrophic Lateral Sclerosis (ALS) Families Project",[],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.179000Z"]